BioSpace News Archive

Ferring Pharmaceuticals (US) today announced that it will be presenting five company-sponsored abstracts at the 2019 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo taking place on October 12-16, 2019, in Philadelphia, Pennsylvania.

Dartmouth College professor recognized for application of artificial intelligence to histopathology

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, today announced the appointment of Mark Foley as President and CEO, replacing Dan Browne, who has stepped down due to a misjudgment in handling an employee matter.

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced findings from an open-label, single-arm pilot study, which examined the impact of SkinTE™, a novel human cellular and tissue-based product derived from a patient’s own skin, in closing venous stasis leg ulcers (VLUs) following failure of conventional treatments.

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company, today announced the promotion of Chief Operating Officer Ari Hoffnung to the newly created role of Chief Strategy Officer.

Bongo® Rx, an FDA cleared medical device for the treatment of mild to moderate obstructive sleep apnea, utilizes no electricity or batteries.

Varian (NYSE: VAR) in collaboration with Cincinnati Children’s Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*.

Univfy®, an AI platform company whose mission is to improve fertility patients’ experience and access to in vitro fertilization (IVF), announced today a collaboration with BBVA USA, the US subsidiary of global financial institution BBVA, to offer a finance program with rates starting at 0% APR (up to 18.99%).

Dr. Wise noted that there are a few implicit issues surrounding the use of AB, “First, there has been some controversy over the cardiovascular safety of aclidinium, which this study shows not to be a problem.

There is nearly a 40% chance of overdiagnosing chronic obstructive pulmonary disease (COPD) when spirometry is not combined with bronchodilator (BD) testing, often missing asthma and asthma-COPD overlap syndrome (ACOS), according to Srinadh Annangi, MD, from the University of Kentucky, School of Medicine, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans